ФАРМАКОНАДЗОР MonographKolbin A.S., Kolbin A.S., Zyryanov S.K., Zyryanov S.K., Belousov D.Yu., Belousov D.Yu., Логиновская О.А., Матвеев А.В., Romanov B.K., Глаголев С.В., Plavinsky S.L., Burbello A.T., Zagorodnikova K.A., Karpenko L.I.ОКИ: Буки-Веди. 2019. 248 с.
AVAILABILITY OF PHARMACOTHERAPY FOR BRONCHIAL ASTHMA WITH REGARD TO THE PHENOTYPE IN THE HOSPITAL: AN ANALYSIS OF ROUTINE PRACTICE ArticleIvanov Dmitriy, Butranova O.I., Zyryanov S.K.SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 91 с.
ЭКОНОМИЧЕСКАЯ ЦЕЛЕСООБРАЗНОСТЬ ПРИМЕНЕНИЯ ИММУНОБИОЛОГИЧЕСКОГО ПРЕПАРАТА ОМАЛИЗУМАБ У ПАЦИЕНТОВ С ТЯЖЕЛОЙ БРОНХИАЛЬНОЙ АСТМОЙ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ ArticleЗырянов С.К., Белевский А.С., Дьяков И.Н.Астма и аллергия. 2019. С. 28-37
PARAPROCTITIS: ETIOLOGY AND CURRENT FEATURES OF PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS ArticleRodoman G.V., Zyryanov S.K., Ivzhits M.A., Romashov O.M., Alexandrov M.I., Putsman G.A., Ionidi P.V.Хирург. 2019. С. 40-49
EFFICIENCY AND SAFETY OF OPIOID THERAPY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH CANCER OF THE REFRACTORY IRON: CLINICO-PATHOGENETIC FEATURES ArticleBobrova O.P., Schneider N.A., Petrova M.M., Dmitrenko D.V., Zyryanov S.K., Zobova S.N.Экспериментальная и клиническая гастроэнтерология. 2019. С. 45-51
CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS ArticleZyryanov S.K., Dyakov I.N.Качественная клиническая практика. 2019. С. 23-32
MEDICATION ERRORS ASSOCIATED WITH BETA-LACTAM ANTIBIOTICS: ANALYSIS OF RUSSIAN SPONTANEOUS REPORTING DATABASE ArticleKuzmina A.V., Asetskaya I.L., Polivanov V.A., Zyryanov S.K.Antibiotiki i Khimioterapiya. Том 64. 2019. С. 48-53
COMPARATIVE PHARMACOECONOMICS OF BX IN THE TREATMENT OF PATIENTS WITH UNCONTROLLED MODERATE AND SEVERE ATOPIC ASTHMA IN THE RUSSIAN HEALTH CARE SETTING ArticleZyryanov S., Dyakov I.Value in Health. Том 22. 2019.
CARDIOVASCULAR COMPLICATIONS OF IMMUNE CHECKPOINT INHIBITORS ArticleKulieva A.A., Emelina E.I., Gendlin G.E., Nikitin I.G., Zyryanov S.K., Varentsov S.I., Zakharova I.I.Качественная клиническая практика. 2019. С. 55-65
GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE ArticleTkacheva O.N., Belenkov Y.N., Karpov Y.A., Zyryanov S.K.Kardiologiia. Том 59. 2019. С. 54-63
QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS ArticleIvanov D.A., Kubaeva M.B., Zyryanov S.K.Фармакоэкономика: теория и практика. Том 7. 2019. С. 38-39
ABDOMINAL INFECTION. ANALYSIS, COMPARISON AND APPROACHES TO ANTIBIOTIC THERAPY: RUSSIAN AND INTERNATIONAL EXPERIENCE AND RECOMMENDATIONS ArticleRodoman G.V., Zyryanov S.K., Romashov O.M., Ivzhits M.A., Putsman G.A., Ionidi P.V., Kosenko O.A., Chenkurov M.S.Хирург. 2019. С. 45-59
CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND ArticleBobrova O.P., Shnayder N.A., Dychno Y.A., Zyryanov S.K., Petrova M.M.Russian Open Medical Journal. Том 8. 2019.
MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA ArticleZyryanov Sergey, Dyakov Ilya, Karpov OlegКачественная клиническая практика. 2019. С. 4-12
ВОЗРАСТНЫЕ ОСОБЕННОСТИ ФАРМАКОКИНЕТИКИ ЦИПРОФЛОКСАЦИНА У ДЕТЕЙ, БОЛЬНЫХ МУКОВИСЦИДОЗОМ ArticleКондратьева Е.И., Кондакова Ю.А., Зырянов С.К., Бондарева И.Б., Воронкова А.Ю., Шерман В.Д., Мельяновская Ю.Л.Клиническая микробиология и антимикробная химиотерапия. Том 21. 2019. 37 с.